| NCT Number | NCT06778811 |
| Lead Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Conditions | Sleep Wake Disorders, Esketamine and the Quality of Recovery, Dexmedetomidine |
| Enrollment | 180 participants |
| Start Date | 2024-10-11 |
| Primary Completion | 2025-09 (estimated) |
| Study Completion | 2025-09 (estimated) |
| Updated on ClinicalTrials.gov | 2025-02-07 |